glycine has been researched along with EBV Infections in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Zheng, AJL | 1 |
| Thermou, A | 1 |
| Daskalogianni, C | 1 |
| Malbert-Colas, L | 1 |
| Karakostis, K | 1 |
| Le Sénéchal, R | 1 |
| Trang Dinh, V | 1 |
| Tovar Fernandez, MC | 1 |
| Apcher, S | 1 |
| Chen, S | 1 |
| Blondel, M | 1 |
| Fahraeus, R | 1 |
| Ganguly, S | 1 |
| Kuravi, S | 1 |
| Alleboina, S | 1 |
| Mudduluru, G | 1 |
| Jensen, RA | 1 |
| McGuirk, JP | 1 |
| Balusu, R | 1 |
| Ruprecht, K | 1 |
| Wunderlich, B | 1 |
| Gieß, R | 1 |
| Meyer, P | 1 |
| Loebel, M | 1 |
| Lenz, K | 1 |
| Hofmann, J | 1 |
| Rosche, B | 1 |
| Wengert, O | 1 |
| Paul, F | 1 |
| Reimer, U | 1 |
| Scheibenbogen, C | 1 |
| Liu, CD | 1 |
| Cheng, CP | 1 |
| Fang, JS | 1 |
| Chen, LC | 1 |
| Zhao, B | 1 |
| Kieff, E | 1 |
| Peng, CW | 1 |
| Dantuma, NP | 1 |
| Sharipo, A | 1 |
| Masucci, MG | 1 |
| Lee, SP | 1 |
| Brooks, JM | 1 |
| Al-Jarrah, H | 1 |
| Thomas, WA | 1 |
| Haigh, TA | 1 |
| Taylor, GS | 1 |
| Humme, S | 1 |
| Schepers, A | 1 |
| Hammerschmidt, W | 1 |
| Yates, JL | 1 |
| Rickinson, AB | 1 |
| Blake, NW | 1 |
1 review available for glycine and EBV Infections
| Article | Year |
|---|---|
Avoiding proteasomal processing: the case of EBNA1.
Topics: Alanine; Antigen Presentation; Cysteine Endopeptidases; Epstein-Barr Virus Infections; Epstein-Barr | 2002 |
5 other studies available for glycine and EBV Infections
| Article | Year |
|---|---|
The nascent polypeptide-associated complex (NAC) controls translation initiation in cis by recruiting nucleolin to the encoding mRNA.
Topics: Alanine; Epstein-Barr Virus Infections; Epstein-Barr Virus Nuclear Antigens; Glycine; Herpesvirus 4, | 2022 |
Targeted Therapy for EBV-Associated B-cell Neoplasms.
Topics: Antineoplastic Agents; Boron Compounds; Cell Line, Tumor; Epstein-Barr Virus Infections; G2 Phase Ce | 2019 |
Multiple sclerosis: the elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1.
Topics: Adult; Alanine; Antibody Formation; Antigens, Viral; Epitopes; Epstein-Barr Virus Infections; Epstei | 2014 |
Modulation of Epstein-Barr virus nuclear antigen 2-dependent transcription by protein arginine methyltransferase 5.
Topics: Amino Acid Sequence; Arginine; Cell Line, Tumor; Epstein-Barr Virus Infections; Epstein-Barr Virus N | 2013 |
CD8 T cell recognition of endogenously expressed epstein-barr virus nuclear antigen 1.
Topics: Alanine; Amino Acid Sequence; Burkitt Lymphoma; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Epstei | 2004 |